Evidence map›Paper›PMID 42120315›Full record

ArticleImmunology2026

High-Dimensional Immune Profiling Identifies Circulating NKT-Like Cells Associated With Severity Outcome in Acute Pancreatitis at Disease Onset.

Carolina González de Castro, Mª Lourdes Ruiz Rebollo, Paloma Cal-Sabater, Elisa Arribas-Rodríguez, Álvaro Martín-Muñoz, Alejandro Gonzalez Del Hierro, Marina Perez Mazzali, Jessica Matesanz-Isabel, Hugo Gonzalo-Benito, Sara Cuesta-Sancho and 1 more

Abstract read
In one paragraph

Article in Immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Carolina González de CastroMucosal Immunology Laboratory, Institute of Biomedicine and Molecular Genetics (IBGM), Universidad de Valladolid-CSIC, Valladolid, Spain.ORCID https://orcid.org/0000-0001-9429-8386
Mª Lourdes Ruiz RebolloGastroenterology Department, Hospital Clínico Universitario de Valladolid, Valladolid, Spain.ORCID https://orcid.org/0000-0003-4600-9257
Paloma Cal-SabaterMucosal Immunology Laboratory, Institute of Biomedicine and Molecular Genetics (IBGM), Universidad de Valladolid-CSIC, Valladolid, Spain.ORCID https://orcid.org/0000-0003-0267-794X
Elisa Arribas-RodríguezMucosal Immunology Laboratory, Institute of Biomedicine and Molecular Genetics (IBGM), Universidad de Valladolid-CSIC, Valladolid, Spain.ORCID https://orcid.org/0000-0002-4470-075X
Álvaro Martín-MuñozFlow Cytometry Unit, Institute of Biomedicine and Molecular Genetics (IBGM), Universidad de Valladolid-CSIC, Valladolid, Spain.ORCID https://orcid.org/0000-0002-6329-2827
Alejandro Gonzalez Del HierroMucosal Immunology Laboratory, Institute of Biomedicine and Molecular Genetics (IBGM), Universidad de Valladolid-CSIC, Valladolid, Spain.ORCID https://orcid.org/0009-0002-1297-9474
Marina Perez MazzaliMucosal Immunology Laboratory, Institute of Biomedicine and Molecular Genetics (IBGM), Universidad de Valladolid-CSIC, Valladolid, Spain.ORCID https://orcid.org/0009-0007-7019-3943
Jessica Matesanz-IsabelUnidad de apoyo a la investigación, Hospital Clínico Universitario, Valladolid, Spain.
Hugo Gonzalo-BenitoUnidad de apoyo a la investigación, Hospital Clínico Universitario, Valladolid, Spain.ORCID https://orcid.org/0000-0001-8340-9909
Sara Cuesta-SanchoMucosal Immunology Laboratory, Institute of Biomedicine and Molecular Genetics (IBGM), Universidad de Valladolid-CSIC, Valladolid, Spain.ORCID https://orcid.org/0000-0002-9890-1063
David BernardoMucosal Immunology Laboratory, Institute of Biomedicine and Molecular Genetics (IBGM), Universidad de Valladolid-CSIC, Valladolid, Spain.ORCID https://orcid.org/0000-0002-2843-6696

Funding

Junta de Castilla y León IR2020-1-UVA01Junta de Castilla y León IR2021-UVA04Spanish Ministry of Science PID2023-148270OB-I00
6 · The paper itself

Abstract

Acute pancreatitis (AP) patients can be classified into mild or severe outcome based on the presence of organ failure days during hospitalization. However, there are no biomarkers that can predict severity outcome. This study aim is to perform an unbiased characterization of the circulating immunome of AP patients at hospital admission aiming to identify novel biomarkers which could predict disease outcome prior to the onset of organ damage and clinical deterioration. Peripheral blood mononuclear cells (PBMC) were collected from newly hospitalized AP patients. Based on their evolution, patients were classified following the Modified Atlanta classification into mild acute pancreatitis (mAP) (n = 20) as well as moderately and/or severe acute pancreatitis (ms-sAP) (n = 20). PBMC were analysed by high-dimensional spectral cytometry with unsupervised dimensionality reduction and clustering algorithms based on the subsequent outcome of the patients. Results were further validated by classical gating and functional approaches with a smaller cohort (n = 8 mAP and n = 8 ms-sAP). A total of 120 different immune cell clusters were identified and characterized in AP patients at hospitalization. Following computational analysis and classical gating validation approaches, circulating CD2

Indexed as

Natural Killer T-CellsPancreatitisAcute DiseaseAdultAgedBiomarkersFemaleFlow CytometryHumansImmunophenotypingMaleMiddle AgedPrognosisSeverity of Illness IndexBiomarkersacute pancreatitisbiomarkersimmune systemNKT‐like cellsspectral cytometry

Identifiers

PMID42120315
PMCPMC13327138

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.